Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines

mBio

Volumn 4, Issue 1, 2013, Pages

  Morales, Diana K ^a,c   Grahl, Nora ^a   Okegbe, Chinweike ^b   Dietrich, Lars E P ^b   Jacobs, Nicholas J ^a   Hogan, Deborah A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; GLYCEROL; PHENAZINE 1 CARBOXYLATE; PHENAZINE DERIVATIVE; PHENAZINE METHOSULFATE; PYOCYANINE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT;

ARTICLE; BACTERIUM COLONY; BIOFILM; CANDIDA ALBICANS; CARBON SOURCE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FERMENTATION OPTIMIZATION; FUNGAL COLONIZATION; FUNGAL GENE; FUNGAL METABOLISM; FUNGUS GROWTH; GENE REPRESSION; HWP1 GENE; METABOLIC REGULATION; MICROBIAL RESPIRATION; MUTANT; NONHUMAN; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; WILD TYPE; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; ELECTRON TRANSPORT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; ORGANISMAL INTERACTION; PHYSIOLOGY;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CULTURE MEDIA; ELECTRON TRANSPORT; METABOLIC NETWORKS AND PATHWAYS; MICROBIAL INTERACTIONS; PHENAZINES; PSEUDOMONAS AERUGINOSA;

MLCS; MLOWN;

EID: 84874617652     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00526-12     Document Type: Article

References (64)

1. Odds FC. 1987. Candida infections: an overview. Crit. Rev. Microbiol. 15:1-5.
2. Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 16:737-748.
3. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell 2:1053-1060.
4. Xie Z, Thompson A, Sobue T, Kashleva H, Xu H, Vasilakos J, Dongari-Bagtzoglou A. 2012. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J. Infect. Dis. 15:1936-1945.
5. Nett J, Andes D. 2006. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol. 9:340-345.
6. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
7. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, Mitchell AP. 2008. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol. 18:1017-1024.
8. Kim J, Sudbery P. 2011. Candida albicans, a major human fungal pathogen. J. Microbiol. 49:171-177.
9. Whiteway M, Bachewich C. 2007. Morphogenesis in Candida albicans. Annu. Rev. Microbiol. 61:529-553.
10. Mulhern SM, Logue ME, Butler G. 2006. Candida albicans transcription factor Ace2 regulates metabolism and is required for filamentation in hypoxic conditions. Eukaryot. Cell 5:2001-2013.
11. Kim SY, Kim J. 2010. Roles of dihydrolipoamide dehydrogenase Lpd1 in Candida albicans filamentation. Fungal Genet. Biol. 47:782-788.
12. Land GA, McDonald WC, Stjernholm RL, Friedman L. 1975. Factors affecting filamentation in Candida albicans: changes in respiratory activity of Candida albicans during filamentation. Infect. Immun. 12:119-127.
13. McDonough JA, Bhattacherjee V, Sadlon T, Hostetter MK. 2002. Involvement of Candida albicans NADH dehydrogenase complex I in filamentation. Fungal Genet. Biol. 36:117-127.
14. Setiadi ER, Doedt T, Cottier F, Noffz C, Ernst JF. 2006. Transcriptional response of Candida albicans to hypoxia: linkage of oxygen sensing and Efg1p-regulatory networks. J. Mol. Biol. 361:399-411.
15. Vellucci VF, Gygax SE, Hostetter MK. 2007. Involvement of Candida albicans pyruvate dehydrogenase complex protein X (Pdx1) in filamentation. Fungal Genet. Biol. 44:979-990.
16. Watanabe T, Ogasawara A, Mikami T, Matsumoto T. 2006. Hyphal formation of Candida albicans is controlled by electron transfer system. Biochem. Biophys. Res. Commun. 348:206-211.
17. Peleg AY, Hogan DA, Mylonakis E. 2010. Medically important bacterialfungal interactions. Nat. Rev. Microbiol. 8:340-349.
18. Morales DK, Hogan DA. 2010. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog. 6:e1000886.
19. Shirtliff ME, Peters BM, Jabra-Rizk MA. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 299: 1-8.
20. Lynch AS, Robertson GT. 2008. Bacterial and fungal biofilm infections. Annu. Rev. Med. 59:415-428.
21. Leclair LW, Hogan DA. 2010. Mixed bacterial-fungal infections in the CF respiratory tract. Med. Mycol. 48:S125-S132.
22. Brand A, Barnes JD, Mackenzie KS, Odds FC, Gow NA. 2008. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 287:48-55.
23. Hogan DA, Kolter R. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229-2232.
24. Gibson J, Sood A, Hogan DA. 2009. Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 75:504-513.
25. Cugini C, Calfee MW, Farrow JM, III, Morales DK, Pesci EC, Hogan DA. 2007. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol. 65:896-906.
26. Hogan DA, Vik A, Kolter R. 2004. A Pseudomonas aeruginosa quorumsensing molecule influences Candida albicans morphology. Mol. Microbiol. 54:1212-1223.
27. Kerr JR. 1994. Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J. Clin. Microbiol. 32:525-527.
28. Cugini C, Morales DK, Hogan DA. 2010. Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasRdefective Pseudomonas aeruginosa strains. Microbiology 156:3096-3107.
29. Morales DK, Jacobs N, Rajamani S, Krishnamurthy M, Cubillos-Ruiz J, Hogan D. 2010. Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms. Mol. Microbiol. 78:1379-1392.
30. Mavrodi DV, Parejko JA, Mavrodi OV, Kwak YS, Weller DM, Blankenfeldt W, Thomashow LS. 2012. Recent insights into the diversity, frequency and ecological roles of phenazines in fluorescent Pseudomonas spp. Environ. Microbiol. http://dx.doi.org/10.1111/j.1462-2920.2012.02846.x.
31. O'Malley YQ, Abdalla MY, McCormick ML, Reszka KJ, Denning GM, Britigan BE. 2003. Subcellular localization of Pseudomonas pyocyanin cytotoxicity in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:L420-L430.
32. French SW, Palmer DS, Sim WA. 1973. Phenazine methosulfate uptake by rat liver mitochondria. Can. J. Biochem. 51:235-240.
33. Hunter RC, et al. 2012. Phenazine content in the cystic fibrosis respira-tory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell Mol. Biol. 47:738-745.
34. Kasozi DM, Gromer S, Adler H, Zocher K, Rahlfs S, Wittlin S, Fritz-Wolf K, Schirmer RH, Becker K. 2011. The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue. Redox Rep. 16:154-165.
35. Schirmer RH, Adler H, Pickhardt M, Mandelkow E. 2011. Lest we forget you-methylene blue. Neurobiol. Aging 32:e7-16.
36. Kerr JR, et al. 1999. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52:385-387.
37. Martinez JP, et al. 1990. Wall mannoproteins in cells from colonial phenotypic variants of Candida albicans. J. Gen. Microbiol. 136: 2421-2432.
38. Ene IV, Bennett RJ. 2009. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot. Cell 8:1909-1913.
39. Staab JF, Bradway SD, Fidel PL, Sundstrom P. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535-1538.
40. El Barkani A, Kurzai O, Fonzi WA, Ramon A, Porta A, Frosch M, Muhlschlegel FA. 2000. Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans. Mol. Cell. Biol. 20:4635-4647.
41. Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, Lorenz MC. 2011. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. mBio 2:e00055-11.
42. Zikánová B, Kuthan M, Ricicová M, Forstová J, Palková Z. 2002. Amino acids control ammonia pulses in yeast colonies. Biochem. Biophys. Res. Commun. 294:962-967.
43. Brown AJ. 2006. Integration of metabolism with virulence in Candida albicans, p 185-203. In Brown AJ (ed), Fungal genomics. Mycota, vol XIII. Springer-Verlag, Heidelberg, Germany.
44. Davis D, Wilson RB, Mitchell AP. 2000. RIM101-dependent andindependent pathways govern pH responses in Candida albicans. Mol. Cell. Biol. 20:971-978.
45. Rich PR, Mischis LA, Purton S, Wiskich JT. 2001. The sites of interaction of triphenyltetrazolium chloride with mitochondrial respiratory chains. FEMS Microbiol. Lett. 202:181-187.
46. Wolfe AJ. 2005. The acetate switch. Microbiol. Mol. Biol. Rev. 69:12-50.
47. Hassan HM, Fridovich I. 1979. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds. Arch. Biochem. Biophys. 196:385-395.
48. Biswas SK, Chaffin WL. 2005. Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm. Curr. Microbiol. 51:100-104.
49. Szawatkowski M, Hamilton-Miller J. 1978. Anaerobic growth and sensitivity of Candida albicans. Microbios Lett. 5:61-66.
50. Bonhomme J, et al. 2011. Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans. Mol. Microbiol. 80:995-1013.
51. Römling U. 2005. Characterization of the rdar morphotype, a multicellular behaviour in Enterobacteriaceae. Cell. Mol. Life Sci. 62:1234-1246.
52. Yildiz FH, Schoolnik GK. 1999. Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc. Natl. Acad. Sci. U. S. A. 96:4028-4033.
53. Friedman L, Kolter R. 2004. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 186:4457-4465.
54. Dietrich LE, Okegbe C, Price-Whelan A, Sakhtah H, Hunter RC, Newman DK. 2013. Bacterial community morphogenesis is intimately linked to the intracellular redox state. J. Bacteriol. http://dx.doi.org/10.1128/JB.02273-12.
55. Wang Y, Kern SE, Newman DK. 2010. Endogenous phenazine antibiotics promote anaerobic survival of Pseudomonas aeruginosa via extracellular electron transfer. J. Bacteriol. 192:365-369.
56. Price-Whelan A, Dietrich LE, Newman DK. 2007. Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14. J. Bacteriol. 189:6372-6381.
57. Dietrich LE, Teal TK, Price-Whelan A, Newman DK. 2008. Redoxactive antibiotics control gene expression and community behavior in divergent bacteria. Science 321:1203-1206.
58. Ramos I, Dietrich LE, Price-Whelan A, Newman DK. 2010. Phenazines affect biofilm formation by Pseudomonas aeruginosa in similar ways at various scales. Res. Microbiol. 161:187-191.
59. Mukherjee PK, Mohamed S, Chandra J, Kuhn D, Liu S, Antar OS, Munyon R, Mitchell AP, Andes D, Chance MR, Rouabhia M, Ghannoum MA. 2006. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect. Immun. 74:3804-3816.
60. Visarius TM, Stucki JW, Lauterburg BH. 1997. Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett. 412:157-160.
61. Hassan HM, Fridovich I. 1980. Mechanism of the antibiotic action pyocyanine. J. Bacteriol. 141:156-163.
62. Chotirmall SH, O'Donoghue E, Bennett K, Gunaratnam C, O'Neill SJ, McElvaney NG. 2010. Sputum Candida albicans presages FEV1 decline and hospitalized exacerbations in cystic fibrosis. Chest 138:1186-1195.
63. Bhargava V, Tomashefski JF, Jr, Stern RC, Abramowsky CR. 1989. The pathology of fungal infection and colonization in patients with cystic fibrosis. Hum. Pathol. 20:977-986.
64. Ogur M, St. John R, Nagai S. 1957. Tetrazolium overlay technique for population studies of respiration deficiency in yeast. Science 125:928-929.